Carlsmed, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Carlsmed, Inc. (CARL) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.22 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- Carlsmed, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 4.08M shares, a 76.85% decline year-over-year.
- Carlsmed, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 17.62M shares.
- Carlsmed, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 3.40M shares, a 78.80% decline from fiscal 2024.
- Carlsmed, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 16.02M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 4.22M shares 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | 4.08M shares 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | 3.40M shares 10-K · filed 2026-02-25 | |||
| 2025-09-30 | 3.39M shares 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 17.67M shares 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | 17.62M shares 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | 16.02M shares 10-K · filed 2026-02-25 | |||
| 2024-09-30 | 15.71M shares 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | 14.37M shares 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |